Syzygium cumini (L.) Skeels (family Myrtaceae), commonly known as jambolão, jambolan, or jamun, has been suggested as a potential source of bioactive molecules against diabetes and associated cardiometabolic diseases. A wide variety of secondary compounds, mainly, terpenes, and phenolic compounds, such as phenolic acids, flavonoids, and tannins, are present in different parts of this plant species. This chapter describes about the various pharmacological properties of S. cumini, including antihyperglycemic, antihyperlipidemic, antiinflammatory, and antioxidant activities, which make it a very interesting species for multitarget therapeutic purposes. Geographical distribution, botanical description, as well as potential of this plant species for in vitro culture have been discussed. Review of literature shows that despite the recalcitrant nature of this plant species, attempts have been made to standardize the protocol for its micropropagation. Although cells and tissues of S. cumini have capacity for in vitro production of bioactive compounds, but basic studies for their mechanisms of production as well as full understanding of biosynthesis pathways are required to be known to exploit the potential of this plant species. Further research towards employing novel elicitors, two-phase culture system, and metabolic engineering may also help in improving the performance of S. cumini under in vitro culture system.